Changes related to "Cyclophosphamide (Cytoxan)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 23:18, 22 September 2018
   
Page name:

22 September 2018

 m   21:43  Breast cancer‎‎ (3 changes | history) . . (+2,247). . [Jwarner‎ (3×)]
 m    21:43 (cur | prev) . . (+223). . Jwarner (talk | contribs) (EC {{#subobject:8d8dbe|Regimen=1}})
 m    10:14 (cur | prev) . . (+1,007). . Jwarner (talk | contribs) (Doxorubicin monotherapy {{#subobject:4f9e89|Regimen=1}})
 m    10:13 (cur | prev) . . (+1,017). . Jwarner (talk | contribs) (Doxorubicin monotherapy {{#subobject:8a2b88|Regimen=1}})
 m   19:33  Prostate cancer‎ (diff | hist) . . (+10,784). . Jwarner (talk | contribs)

21 September 2018

 m   20:47  Breast cancer‎‎ (2 changes | history) . . (+3,307). . [Jwarner‎ (2×)]
 m    20:47 (cur | prev) . . (+1,199). . Jwarner (talk | contribs) (FEC {{#subobject:ed96e7|Regimen=1}})
 m    14:46 (cur | prev) . . (+2,108). . Jwarner (talk | contribs) (ddFEC {{#subobject:45dbc1|Regimen=1}})

20 September 2018

 m   16:58  Breast cancer‎‎ (2 changes | history) . . (+1,470). . [Jwarner‎ (2×)]
 m    16:58 (cur | prev) . . (+1,194). . Jwarner (talk | contribs)
 m    16:29 (cur | prev) . . (+276). . Jwarner (talk | contribs) (St Gallen Breast Guidelines)

18 September 2018

 m   17:16  Glioblastoma‎ (diff | hist) . . (+1,273). . Jwarner (talk | contribs) (Radiation therapy {{#subobject:7dbd68|Regimen=1}})
 m   16:57  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+2,320). . Jwarner (talk | contribs) (Daunorubicin, L-Asparaginase, Vincristine, Prednisone {{#subobject:3c9897|Regimen=1}})
 m   11:10  Hodgkin lymphoma‎ (diff | hist) . . (+900). . Jwarner (talk | contribs)

17 September 2018

 m   22:51  Prostate cancer‎ (diff | hist) . . (0). . Jwarner (talk | contribs) (Apalutamide monotherapy {{#subobject:a70eae |Regimen=1}})
 m   22:40  Acute myeloid leukemia‎‎ (2 changes | history) . . (+1,138). . [Jwarner‎ (2×)]
 m    22:40 (cur | prev) . . (+1,057). . Jwarner (talk | contribs) (Gemtuzumab ozogamicin monotherapy {{#subobject:712055|Regimen=1}})
 m    22:35 (cur | prev) . . (+81). . Jwarner (talk | contribs)
 m   22:14  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+4). . Warner-admin (talk | contribs) (Text replacement - "'''Subset analysis:'''" to "'''Subgroup analysis:'''")
     21:49  Hodgkin lymphoma‎ (diff | hist) . . (+3,047). . Jwarner (talk | contribs)
 m   15:35  Glioblastoma‎ (diff | hist) . . (+89). . Jwarner (talk | contribs) (Recurrent disease, non-curative salvage therapy)

16 September 2018

 m   21:43  Hodgkin lymphoma‎‎ (2 changes | history) . . (+687). . [Jwarner‎ (2×)]
 m    21:43 (cur | prev) . . (+1,953). . Jwarner (talk | contribs) (CBV, then auto HSCT {{#subobject:935235|Regimen=1}})
 m    21:37 (cur | prev) . . (-1,266). . Jwarner (talk | contribs) (BEAM, then auto HSCT {{#subobject:ed61ad|Regimen=1}})
 m   18:46  Follicular lymphoma‎ (diff | hist) . . (+198). . Jwarner (talk | contribs) (Ofatumumab monotherapy {{#subobject:a875bf|Regimen=1}})
 m   16:22  Small cell lung cancer‎ (diff | hist) . . (+1,200). . Jwarner (talk | contribs) (ACE {{#subobject:9fbf31|Regimen=1}})
     12:53  Prostate cancer‎‎ (2 changes | history) . . (+1,813). . [Jwarner‎; PeterYang‎]
 m    12:53 (cur | prev) . . (-1). . Jwarner (talk | contribs) (References)
      12:10 (cur | prev) . . (+1,814). . PeterYang (talk | contribs) (added apalutamide)
 m   12:46  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+129). . Jwarner (talk | contribs) (Idelalisib monotherapy {{#subobject:b872c5|Regimen=1}})
 m   12:40  Breast cancer‎ (diff | hist) . . (+1,267). . Jwarner (talk | contribs) (Variant #16, 1200/50/1200 x 6 {{#subobject:d46835|Variant=1}})
 m   12:34  Bladder cancer‎‎ (2 changes | history) . . (+33). . [Jwarner‎ (2×)]
 m    12:34 (cur | prev) . . (+17). . Jwarner (talk | contribs)
 m    12:31 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)
 m   11:28  CNS lymphoma‎ (diff | hist) . . (+63). . PeterYang (talk | contribs) (CYVE {{#subobject:b2c919|Regimen=1}}: correction of etoposide dose)
 m   09:41  Anaplastic glioma‎‎ (2 changes | history) . . (+1,447). . [Jwarner‎ (2×)]
 m    09:41 (cur | prev) . . (+24). . Jwarner (talk | contribs) (Irinotecan monotherapy {{#subobject:44d48a|Regimen=1}})
 m    09:41 (cur | prev) . . (+1,423). . Jwarner (talk | contribs) (Irinotecan monotherapy {{#subobject:44d48a|Regimen=1}})

15 September 2018

 m   23:04  Acute myeloid leukemia‎ (diff | hist) . . (+743). . Jwarner (talk | contribs) (Clofarabine monotherapy {{#subobject:18ac50|Regimen=1}})
 m   22:47  Hodgkin lymphoma‎‎ (2 changes | history) . . (-407). . [Jwarner‎ (2×)]
 m    22:47 (cur | prev) . . (-423). . Jwarner (talk | contribs) (References)
 m    22:40 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)